B-CELL MALIGNANCY

Clinical trials for B-CELL MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new B-CELL MALIGNANCY trials appear

Sign up with your email to follow new studies for B-CELL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Terminated 1

CRISPR gene editing used to create 'Ready-Made' cancer therapy

Disease control Terminated

This study tested a new type of cell therapy called CTX110 for adults with B-cell cancers that have returned or not responded to other treatments. The therapy uses immune cells (T cells) from healthy donors that are modified using CRISPR gene-editing technology to target cancer. …

Matched conditions: B-CELL MALIGNANCY

Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

B-CELL MALIGNANCY

Get alerted when new B-CELL MALIGNANCY trials appear

CRISPR gene editing used to create 'Ready-Made' cancer therapy